MANILA – The Department of Health (DOH) has allocated P18 million for the clinical trials of Japanese anti-influenza drug Avigan on coronavirus patients, President Rodrigo Duterte said Monday (May 18).
Around 80 to 100 patients are expected to undergo clinical trials. Avigan is an anti-flu medication approved for use in flu outbreaks in Japan. It has also been deployed to treat Ebola in the past.
“The DOH, through its Advancing Health through Evidence- Assisted Decisions with Health Policy and System Research, has allocated P18 million for Avigan Trials,” Duterte said.
The government is also exploring other clinical studies for the treatment of the coronavirus.
“The Department of Science and Technology (DOST) has also conducted exploratory talks for possible involvement in the clinical trials of several vaccine research groups and organizations abroad,”The President added.
On May 5, The Department of Health announced that the Philippines would receive a free supply of the anti-flu drugs from the Japanese government for Covid-19 treatments. The free supply is part of the $1 million worth of trial drug distributed by Japan to several countries under the United Nations Office for Project Services.